Form4insider filings, from the source

SEC Form 4 · accession 0001144204-16-076318

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 15, 2016
Accepted (ET)
Jan 20, 2016 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2016P1,800$19.8572A2,581,990ISee Footnote
Common StockF1Jan 19, 2016P4,200$19.8763A2,586,190ISee Footnote
Common StockF2,F1Jan 20, 2016P1,803$19.883A2,587,993ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses